Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Depressants01:28

Depressants

Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Structural Mass-Spectrometric Description of Immune Complexes in Vaccine-Induced Immune Thrombocytopenia and Thrombosis.

Journal of the American Chemical Society·2026
Same author

Adenoviral Inciting Antigen and Somatic Hypermutation in VITT.

The New England journal of medicine·2026
Same author

Shared molecular profiles of anti-PL12 autoantibodies in anti-synthetase syndrome.

Rheumatology (Oxford, England)·2025
Same author

Anti-PF4 mediated thrombocytopenia and thrombosis associated with acute cytomegalovirus infection displays both HIT-like and VITT-like characteristics.

British journal of haematology·2025
Same author

VITT-like Monoclonal Gammopathy of Thrombotic Significance.

The New England journal of medicine·2025
Same author

A triad of somatic mutagenesis converges in self-reactive B cells to cause a virus-induced autoimmune disease.

Immunity·2025

Video Experimental Relacionado

Updated: Jul 7, 2026

A Method for Evaluating the Reinforcing Properties of Ethanol in Rats without Water Deprivation, Saccharin Fading or Extended Access Training
07:50

A Method for Evaluating the Reinforcing Properties of Ethanol in Rats without Water Deprivation, Saccharin Fading or Extended Access Training

Published on: January 29, 2017

Un autoanticuerpo funcional en la narcolepsia.

Anthony J F Smith1, Michael W Jackson, Petra Neufing

  • 1Department of Immunology, Allergy and Arthritis, Flinders Medical Centre, Bedford Park, SA 5042, Australia.

Lancet (London, England)
|December 14, 2004
PubMed
Resumen

Los investigadores encontraron un potencial marcador autoinmune para la narcolepsia. La inmunoglobulina G de pacientes con narcolepsia mejoró las respuestas musculares de la vejiga, apoyando la base autoinmune de la narcolepsia-cataplexia.

Más Videos Relacionados

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

Videos de Experimentos Relacionados

Last Updated: Jul 7, 2026

A Method for Evaluating the Reinforcing Properties of Ethanol in Rats without Water Deprivation, Saccharin Fading or Extended Access Training
07:50

A Method for Evaluating the Reinforcing Properties of Ethanol in Rats without Water Deprivation, Saccharin Fading or Extended Access Training

Published on: January 29, 2017

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

Área de la Ciencia:

  • Neuroinmunología La neuroinmunología.
  • Las enfermedades autoinmunes son enfermedades autoinmunes.
  • Trastornos del sueño Los trastornos del sueño.

Sus antecedentes:

  • Se sospecha que la narcolepsia es autoinmune, pero un marcador específico de autoanticuerpos séricos sigue siendo elusivo.
  • La hiperactividad colinérgica es una característica conocida en la narcolepsia-cataplexia.

Objetivo del estudio:

  • Investigar la base autoinmune de la narcolepsia mediante el examen de los efectos funcionales de las IgG derivadas del paciente.
  • Para identificar los autoanticuerpos potenciales que contribuyen a la narcolepsia-cataplexia.

Principales métodos:

  • La inmunoglobulina G (IgG) fue aislada de nueve pacientes con narcolepsia y nueve controles sanos.
  • La IgG se transfirió a ratones para evaluar su efecto en las respuestas contráctiles del músculo liso.
  • Las respuestas se midieron después de la estimulación colinérgica, específicamente utilizando carbacol y acetilcolina liberada neuronalmente.

Principales resultados:

  • La IgG de todos los pacientes con narcolepsia mejoró significativamente las respuestas contráctiles de la vejiga a los agonistas colinérgicos en comparación con la IgG de control (p<0.0001).
  • La mejora fue específica de la vejiga, ya que las contracciones de los vasos deferentes inervados simpáticamente no se alteraron.
  • Esto sugiere un mecanismo autoinmune específico que afecta las vías colinérgicas en la vejiga.

Conclusiones:

  • Los hallazgos proporcionan evidencia directa que apoya la hipótesis autoinmune de la narcolepsia.
  • Un marcador específico de autoanticuerpos en la narcolepsia puede dirigirse a las vías colinérgicas, lo que lleva a síntomas como la cataplexia.
  • Esta investigación abre nuevas vías para las estrategias diagnósticas y terapéuticas para la narcolepsia.